Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report

Neurology

Volumn 86, Issue 3, 2016, Pages 245-252

  Chitnis, Tanuja ^a,b   Ness, Jayne ^c   Krupp, Lauren ^d   Waubant, Emmanuelle ^e   Hunt, Tyler ^f   Olsen, Cody S ^f   Rodriguez, Moses ^g   Lotze, Tim ^h   Gorman, Mark ⁱ   Benson, Leslie ⁱ   Belman, Anita ^d   Weinstock Guttman, Bianca ^j   Aaen, Greg ^k   Graves, Jennifer ^e   Patterson, Marc ^g   Rose, John W ^f   Casper, T Charles ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UAB Center for Pediatric Onset Demyelinating Disease   (United States)

^d Renaissance School of Medicine at Stony Brook University   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j JACOBS NEUROLOGICAL INSTITUTE   (United States)

^k LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G; MYCOPHENOLATE MOFETIL; RITUXIMAB;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FEVER; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; SEIZURE; VOMITING; ADOLESCENT; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; IMMUNOLOGY; INFANT; MULTICENTER STUDY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE PROGRESSION; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SEVERITY OF ILLNESS INDEX;

EID: 84955282017     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002283     Document Type: Article

References (28)

1. Quek AM, McKeon A, Lennon VA, et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol 2012;69:1039-1043.
2. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93-100.
3. Jeffery AR, Buncic JR. Pediatric Devic's neuromyelitis optica. J Pediatric Ophthalmol Strabismus 1996;33:223-229.
4. Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039-1047.
5. Banwell B, Tenembaum S, Lennon VA, et al. Neuromy-elitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344-352.
6. Bencherif MZ, Karib H, Tachfouti S, Guedira K, Mohcine Z. Devic's neuromyelitis optica: a childhood case and review of the literature [in French]. J Fr Ophtalmol 2000;23:488-490.
7. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis op-tica (Devic's syndrome). Neurology 1999;53:1107-1114.
8. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromy-elitis optica. Neurology 2006;66:1485-1489.
9. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis opti-ca spectrum disorders. Neurology 2015;85:177-189.
10. Wingerchuk DM. Neuromyelitis optica spectrum disorders. Continuum 2010;16:105-121.
11. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromy-elitis optica. Lancet Neurol 2007;6:805-815.
12. Casper TC, Rose JW, Roalstad S, et al. The US Network of Pediatric Multiple Sclerosis Centers: development, progress, and next steps. J Child Neurol 2015;10:1381-1387.
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005;58:840-846.
14. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013;19:1261-1267.
15. Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 2011;76:1229-1237.
16. Pohl D, Hennemuth I, von Kries R, Hanefeld F. Paediat-ric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr 2007;166:405-412.
17. Chitnis T. Role of puberty in multiple sclerosis risk and course. Clin Immunol 2013;149:192-200.
18. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919.
19. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202:473-477.
20. Fragoso YD, Ferreira ML, Oliveira EM, et al. Neuromyelitis optica with onset in childhood and adolescence. Pediatr Neurol 2014;50:66-68.
21. Absoud M, Lim MJ, Appleton R, et al. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015;86: 470-472.
22. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012;135: 1834-1849.
23. Collongues N, Marignier R, Zephir H, et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010;75:1084-1088.
24. Huppke P, Rostasy K, Karenfort M, et al. Acute disseminated encephalomyelitis followed by recurrent or mono-phasic optic neuritis in pediatric patients. Mult Scler 2013; 19:941-946.
25. Rostasy K, Mader S, Schanda K, et al. Anti-myelin oligo-dendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012;69:752-756.
26. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014;71:276-283.
27. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014;82:474-481.
28. Rostasy K, Mader S, Hennes EM, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 2013;19:1052-1059.